#Arena Pharmaceuticals (ARNA)

The Week in Review #20 THE MARKET - My friend asked: “Are  you  scared?” “Of  what?” I asked “The  market?” The  market? No,” I  said.  We are afraid of those who are rendering the market nervous and...

Arena Pharmaceuticals (ARNA) announced positive Phase 2 results from the OASIS trial for etrasimod in ulcerative colitis (UC). The Drug: Etrasimod is a selective sphingosine 1-phosphate (S1P) recepto...

Arena (ARNA) announced positive Phase 2 clinical trial results for its drug ralinepag 1 for pulmonary arterial hypertension (PAH). In the 61-patient study, the primary efficacy analysis demonstrated a...

PROHOST   ROUND   TABLE OBESITY DRUGS  Approval Granted, Yes. Are Sales Guaranteed? The FDA approved  Vivus (VVUS)  diet drug,  Qsymia  (previously called Qnexa) – one of three drugs previously reject...

While writing our article about the future, we get news about Biogen Idec (BIIB) entering into a research collaboration with premier academic and research institutions. The agreement aims at sequencin...

Today’s headlines focused on expectations of increasing mergers and acquisitions in the biotech sector with repetition of the fact that  expiring patents are big motive for pharmaceutical companies to...

AN UPCOMING APPROVAL AND PROHOST’S CANCER FIRMS’ PERFORMACES Yes, we have approval decisions coming soon with impact on the developing firms, including  ONYX (ONXX), ARENA (ARNA), VIVUS (VVUS)  and...